BioCentury
ARTICLE | Company News

Alere, Axis-Shield deal

October 3, 2011 7:00 AM UTC

Axis-Shield's board said it was "disappointed" that the "firm rebuttal" from shareholders against Alere's "wholly inadequate offer" has not been noticed by the fellow diagnostics company. Alere reiterated its unsolicited tender offer to acquire Axis-Shield for 460p per share in cash and included a condition that if Alere does not receive valid acceptances for Axis-Shield shares that represent more than 50% of the voting rights by Oct. 10, then the offer will lapse. ...